1. Upregulation of miR‑132‑3p in cholangiocarcinoma tissues: A study based on RT‑qPCR, The Cancer Genome Atlas miRNA sequencing, Gene Expression Omnibus microarray data and bioinformatics analyses
   Hua‑Yu Wu et al, 2019, Molecular Medicine Reports CrossRef
2. Immuno‐oncological role of 20S proteasome alpha‐subunit 3 in aggravating the progression of esophageal squamous cell carcinoma
   Jinyan Liu et al, 2022, European Journal of Immunology CrossRef
3. MLN2238 exerts its anti-tumor effects via regulating ROS/JNK/mitochondrial signaling pathways in intrahepatic cholangiocarcinoma
   Hao Xu et al, 2022, Frontiers in Pharmacology CrossRef
4. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer
   Chung-Chieh Chiao et al, 2021, Diagnostics CrossRef
5. Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events
   Hua‑Yu Wu et al, 2019, Oncology Letters CrossRef
6. Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study
   Kamolwan Watcharatanyatip et al, 2022, Molecules CrossRef